Crowdonomics
Eleison Pharmaceuticals Inc

Reg CF · Convertible Note · Jan 2025

ClosedReg CFConvertible Note
via StartEngine · last checked Aug 17, 2026
Raised
$0 / $1.2M max
0% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$0
−$4.7M
FY2022
$0
−$2.6M
FY2023
RevenueNet income
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$4,722,763
-$2,551,149
Taxes paid
$0
$0
Balance sheet
Cash
$20,972
$10,380
Accounts receivable
$0
$0
Total assets
$729,556
$729,464
Short-term debt
$3,557,680
$3,326,969
Long-term debt
$1,108,677
$2,470,118
Total liabilities
$4,666,357
$5,797,087
Other
Headcount
—
5

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

No priced terms — this is a revenue-share or unpriced offering.

Offering details

Target$124,000
Max$1,235,000
Min investment—
OpenedJan 8, 2025
DeadlineApr 9, 2025
ClosedApr 9, 2025
Days active91

Links & provenance

Source: SEC EDGAR
0001665160-25-000014
Last synced Aug 17, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.